Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis
- PMID: 32144458
- PMCID: PMC7315585
- DOI: 10.1007/s00330-020-06740-w
Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis
Abstract
Objectives: To perform a systematic review on apparent diffusion coefficient (ADC) values of renal tumor subtypes and meta-analysis on the diagnostic performance of ADC for differentiation of localized clear cell renal cell carcinoma (ccRCC) from other renal tumor types.
Methods: Medline, Embase, and the Cochrane Library databases were searched for studies published until May 1, 2019, that reported ADC values of renal tumors. Methodological quality was evaluated. For the meta-analysis on diagnostic test accuracy of ADC for differentiation of ccRCC from other renal lesions, we applied a bivariate random-effects model and compared two subgroups of ADC measurement with vs. without cystic and necrotic areas.
Results: We included 48 studies (2588 lesions) in the systematic review and 13 studies (1126 lesions) in the meta-analysis. There was no significant difference in ADC of renal parenchyma using b values of 0-800 vs. 0-1000 (p = 0.08). ADC measured on selected portions (sADC) excluding cystic and necrotic areas differed significantly from whole-lesion ADC (wADC) (p = 0.002). Compared to ccRCC, minimal-fat angiomyolipoma, papillary RCC, and chromophobe RCC showed significantly lower sADC while oncocytoma exhibited higher sADC. Summary estimates of sensitivity and specificity to differentiate ccRCC from other tumors were 80% (95% CI, 0.76-0.88) and 78% (95% CI, 0.64-0.89), respectively, for sADC and 77% (95% CI, 0.59-0.90) and 77% (95% CI, 0.69-0.86) for wADC. sADC offered a higher area under the receiver operating characteristic curve than wADC (0.852 vs. 0.785, p = 0.02).
Conclusions: ADC values of kidney tumors that exclude cystic or necrotic areas more accurately differentiate ccRCC from other renal tumor types than whole-lesion ADC values.
Key points: • Selective ADC of renal tumors, excluding cystic and necrotic areas, provides better discriminatory ability than whole-lesion ADC to differentiate clear cell RCC from other renal lesions, with area under the receiver operating characteristic curve (AUC) of 0.852 vs. 0.785, respectively (p = 0.02). • Selective ADC of renal masses provides moderate sensitivity and specificity of 80% and 78%, respectively, for differentiation of clear cell renal cell carcinoma (RCC) from papillary RCC, chromophobe RCC, oncocytoma, and minimal-fat angiomyolipoma. • Selective ADC excluding cystic and necrotic areas are preferable to whole-lesion ADC as an additional tool to multiphasic MRI to differentiate clear cell RCC from other renal lesions whether the highest b value is 800 or 1000.
Keywords: Clear cell renal cell carcinoma; Diffusion weighted imaging; Kidney neoplasms; Renal cell carcinoma.
Figures





Similar articles
-
Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.AJR Am J Roentgenol. 2018 Sep;211(3):614-623. doi: 10.2214/AJR.17.19278. Epub 2018 May 29. AJR Am J Roentgenol. 2018. PMID: 29812980
-
Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.Abdom Radiol (NY). 2018 Sep;43(9):2424-2430. doi: 10.1007/s00261-017-1453-4. Abdom Radiol (NY). 2018. PMID: 29520425 Free PMC article.
-
Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.Abdom Radiol (NY). 2017 Jul;42(7):1919-1928. doi: 10.1007/s00261-017-1095-6. Abdom Radiol (NY). 2017. PMID: 28280876
-
Diagnostic Accuracy of MRI for Detection of Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.AJR Am J Roentgenol. 2018 Oct;211(4):812-821. doi: 10.2214/AJR.17.19462. Epub 2018 Jul 31. AJR Am J Roentgenol. 2018. PMID: 30063398 Free PMC article.
-
Chemical shift magnetic resonance imaging for distinguishing minimal-fat renal angiomyolipoma from renal cell carcinoma: a meta-analysis.Eur Radiol. 2018 May;28(5):1854-1861. doi: 10.1007/s00330-017-5141-0. Epub 2017 Nov 24. Eur Radiol. 2018. PMID: 29178029 Review.
Cited by
-
Interstitial Brachytherapy of the Liver for Renal Cell Carcinoma: ADC Measurements Do Not Predict Overall Survival.In Vivo. 2022 Nov-Dec;36(6):2945-2951. doi: 10.21873/invivo.13037. In Vivo. 2022. PMID: 36309358 Free PMC article.
-
Diffusion-Weighted MRI in the Genitourinary System.J Clin Med. 2022 Mar 30;11(7):1921. doi: 10.3390/jcm11071921. J Clin Med. 2022. PMID: 35407528 Free PMC article. Review.
-
Differentiating renal cell carcinoma and oncocytoma with volumetric MRI histogram analysis.North Clin Istanb. 2023 Sep 27;10(5):636-641. doi: 10.14744/nci.2023.26122. eCollection 2023. North Clin Istanb. 2023. PMID: 37829753 Free PMC article.
-
Renal Cell Carcinoma or Oncocytoma? The Contribution of Diffusion-Weighted Magnetic Resonance Imaging to the Differential Diagnosis of Renal Masses.Medicina (Kaunas). 2022 Feb 1;58(2):221. doi: 10.3390/medicina58020221. Medicina (Kaunas). 2022. PMID: 35208545 Free PMC article.
-
Application of different methods used to measure the apparent diffusion coefficient of renal cell carcinoma on the same lesion and its correlation with ISUP nuclear grading.Abdom Radiol (NY). 2022 Jul;47(7):2442-2452. doi: 10.1007/s00261-022-03541-1. Epub 2022 May 16. Abdom Radiol (NY). 2022. PMID: 35570223
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical